Upon oxygen activation, the non-heme diiron enzymes can
generate
various active species for oxidative transformations. In this work,
the catalytic mechanism of the diiron active site (heme-oxygenase-like
diiron oxidase (HDO) domain) in SznF has been comprehensively studied
by molecular docking, classical molecular dynamics (MD) and quantum
mechanical/molecular mechanical (QM/MM) MD simulations, and hybrid
QM/MM calculations. The HDO domain of SznF catalyzes the selective
hydroxylation of Nω-methyl-l-arginine (l-NMA) to generate Nδ-hydroxy-Nω-methyl-l-Arg (l-HMA) and Nδ,Nω-dihydroxy-Nω,-methyl-l-Arg
(l-DHMA), which is a key step in the synthesis of the nitrosourea
pharmacophore of the pancreatic cancer drug streptozotocin (SZN).
Our study shows that the peroxo-diiron(III/III) intermediate in Sznf
maintains a butterfly-like conformation, while the further protonation
of the diiron(III/III) intermediate is found to be inaccessible and
unfavorable thermodynamically. Among various mechanisms, we found
that the most favorable mechanism involves the nucleophilic attack
of the guanidium group onto the peroxo group of P1, which drives the
heterolytic cleavage of the O–O bond. Moreover, the selectivity
of N-hydroxylation by the peroxo-diiron(III/III) intermediate can
be fully supported by MD simulations, suggesting that the peroxo-diiron(III/III)
is the reactive intermediate for N-hydroxylation in SznF. The present
study expands our understanding on the O2 activation and
N-hydroxylation by the non-heme diiron enzymes.